These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 34395160)

  • 21. Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases.
    Kumar BK; Faheem ; Sekhar KVGC; Ojha R; Prajapati VK; Pai A; Murugesan S
    J Biomol Struct Dyn; 2022 Feb; 40(3):1363-1386. PubMed ID: 32981461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of potential bioactive natural compounds from Indonesian medicinal plants against 3-chymotrypsin-like protease (3CL
    Prasetyo WE; Purnomo H; Sadrini M; Wibowo FR; Firdaus M; Kusumaningsih T
    J Biomol Struct Dyn; 2023 Jul; 41(10):4467-4484. PubMed ID: 35470785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CL
    Jawarkar RD; Bakal RL; Zaki MEA; Al-Hussain S; Ghosh A; Gandhi A; Mukerjee N; Samad A; Masand VH; Lewaa I
    Arab J Chem; 2022 Jan; 15(1):103499. PubMed ID: 34909066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of cryptogamic secondary metabolites as putative inhibitors of SARS-CoV-2 main protease and ribosomal binding domain of spike glycoprotein by molecular docking and molecular dynamics approaches.
    Prateeksha G; Rana TS; Ashthana AK; Barik SK; Singh BN
    J Mol Struct; 2021 Sep; 1240():130506. PubMed ID: 33967344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on the mechanism of active components of Liupao tea on 3CL
    Ni WJ; Chen XX; Wei SY; Lan LL; Qiu RJ; Ling YP; Zhou DS; Wu ZM; Cao ZH; Yu CP; Zeng Y
    J Food Biochem; 2021 May; 45(5):e13707. PubMed ID: 33760271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computational studies indicated the effectiveness of human metabolites against SARS-Cov-2 main protease.
    Roy R; Sk MF; Tanwar O; Kar P
    Mol Divers; 2023 Aug; 27(4):1587-1602. PubMed ID: 35978064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme.
    Bahadur Gurung A; Ajmal Ali M; Lee J; Abul Farah M; Mashay Al-Anazi K
    J King Saud Univ Sci; 2020 Sep; 32(6):2845-2853. PubMed ID: 32837113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico discovery of 3 novel quercetin derivatives against papain-like protease, spike protein, and 3C-like protease of SARS-CoV-2.
    Bhattacharya K; Bordoloi R; Chanu NR; Kalita R; Sahariah BJ; Bhattacharjee A
    J Genet Eng Biotechnol; 2022 Mar; 20(1):43. PubMed ID: 35262828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of highly effective inhibitors against SARS-CoV-2 main protease: From virtual screening to in vitro study.
    Wang H; Wen J; Yang Y; Liu H; Wang S; Ding X; Zhou C; Zhang X
    Front Pharmacol; 2022; 13():1036208. PubMed ID: 36467060
    [No Abstract]   [Full Text] [Related]  

  • 31. Natural-like products as potential SARS-CoV-2 M
    Ibrahim MAA; Abdeljawaad KAA; Abdelrahman AHM; Hegazy MF
    J Biomol Struct Dyn; 2021 Sep; 39(15):5722-5734. PubMed ID: 32643529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Identification of Nafamostat and VR23 as COVID-19 drug candidates by targeting 3CL
    Bhowmik D; Sharma RD; Prakash A; Kumar D
    J Mol Struct; 2021 Jun; 1233():130094. PubMed ID: 33612858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular docking and simulation studies on SARS-CoV-2 M
    Lokhande KB; Doiphode S; Vyas R; Swamy KV
    J Biomol Struct Dyn; 2021 Nov; 39(18):7294-7305. PubMed ID: 32815481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of Natural Bisbenzylisoquinoline Analogs from the Library of Thai Traditional Plants as SARS-CoV-2 3CL
    Khamto N; Utama K; Tateing S; Sangthong P; Rithchumpon P; Cheechana N; Saiai A; Semakul N; Punyodom W; Meepowpan P
    J Chem Inf Model; 2023 Apr; 63(7):2104-2121. PubMed ID: 36647612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening of natural compounds from Cyperus rotundus Linn against SARS-CoV-2 main protease (M
    Kumar SB; Krishna S; Pradeep S; Mathews DE; Pattabiraman R; Murahari M; Murthy TPK
    Comput Biol Med; 2021 Jul; 134():104524. PubMed ID: 34090015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosteric Regulation of 3CL Protease of SARS-CoV-2 and SARS-CoV Observed in the Crystal Structure Ensemble.
    Kidera A; Moritsugu K; Ekimoto T; Ikeguchi M
    J Mol Biol; 2021 Dec; 433(24):167324. PubMed ID: 34717972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Silico Identification of New Anti-SARS-CoV-2 Main Protease (M
    Onyango H; Odhiambo P; Angwenyi D; Okoth P
    J Trop Med; 2022; 2022():3697498. PubMed ID: 36263438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repurposing approved drugs as potential inhibitors of 3CL-protease of SARS-CoV-2: Virtual screening and structure based drug design.
    Meyer-Almes FJ
    Comput Biol Chem; 2020 Oct; 88():107351. PubMed ID: 32769050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular modelling and structure-activity relationship of a natural derivative of
    Ayipo YO; Ahmad I; Najib YS; Sheu SK; Patel H; Mordi MN
    J Biomol Struct Dyn; 2023 Mar; 41(5):1959-1977. PubMed ID: 35037841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QSAR and molecular docking studies of isatin and indole derivatives as SARS 3CL
    Soleymani N; Ahmadi S; Shiri F; Almasirad A
    BMC Chem; 2023 Apr; 17(1):32. PubMed ID: 37024955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.